Clinical Trials for Brii Biosciences

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Brii Biosciences

Clinical Trials (3)

NCT06650852
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
PHASE2Recruiting
250 participants
Started: Oct 31, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor14 locations
NCT06491563
Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)
PHASE2Active, not recruiting
150 participants
Started: Aug 6, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors12 locations
NCT05970289
Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients
PHASE2Active, not recruiting
86 participants
Started: Aug 22, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors29 locations